13 completed, 9 not yet recruiting, 9 recruiting, 2 enrolling by invitation. 17 Not applicable, 17 Phase 1, 1 Early Phase 1.
Follow Healthy Subjects (HS): new trials by email Literature Review of Healthy Subjects (HS) trials Research Report on Healthy Subjects (HS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-organ Imaging of Microvascular and Metabolic Function 18F-FDG, Positron Emission Tomography (PET) - Healthy Subjects (HS), Cardiovascular Diseases (CVD) | Early Phase 1 | Not yet recruiting | Massachusetts General Hospital | 60 | 2027-01-01 | 2026-10-28 |
| A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM9528 ISM9528 capsules - Healthy Subjects (HS) | Phase 1 | Recruiting | InSilico Medicine Hong Kong Limited | 1 | 2026-10-29 | 2026-11-12 |
| Bioequivalence Study Between YHP2508A and YHR2601 in Healthy Subjects YHP2508A, YHR2601 - Healthy Subjects (HS) | Phase 1 | Recruiting | Yuhan Corporation | 44 | 2026-10-20 | 2026-11-03 |
| Methodological Study of Exercise and Hypoxic Conditions in Healthy Subjects Exercise and hypoxia - Healthy Subjects (HS), Exercise | Not applicable | Recruiting | University Hospital, Grenoble | 305 | 2026-10-19 | 2026-10-23 |
| Bioequivalence Study Between YHP2508B and YHR2602 in Healthy Subjects YHP2508B, YHR2602 - Healthy Subjects (HS) | Phase 1 | Recruiting | Yuhan Corporation | 44 | 2026-10-16 | 2026-11-03 |
| Effect of Continuous Nebulisation of Isotonic Saline Solution Combined With Heated Humidification on Mucociliary Clearance in Healthy Subjects Heated humidification, Saline Nebulization - Healthy Subjects (HS) | Not applicable | Not yet recruiting | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 10 | 2026-10-01 | 2026-07-23 |
| Reactive Balance Training in Augmented Reality for Older Adults Reactive balance training with augmented reality group, Treadmill walking - Healthy Subjects (HS) | Not applicable | Recruiting | The Hong Kong Polytechnic University | 36 | 2026-07-27 | 2026-10-06 |
| A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969 ISM8969 tablets or placebo - Healthy Subjects (HS), Obese Adult Participants at Risk of Cardiovascular Disease | Phase 1 | Recruiting | InSilico Medicine Hong Kong Limited | 100 | 2026-06-15 | 2026-06-22 |
| Vagus Nerve Stimulation for Reaction Time vagus nerve stimulation - Healthy Subjects (HS) | Not applicable | Recruiting | Youngstown State University | 30 | 2026-04-06 | 2026-04-14 |
| First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics ISH0613 for injection, Placebo - Healthy Subjects (HS), SLE (Systemic Lupus) | Phase 1 | Not yet recruiting | SUNHO(China)BioPharmaceutical CO., Ltd. | 26 | 2026-04-01 | 2026-04-13 |
| Sebum Metabolomics and Lipidomics for Clinical Applications Sebutape sampling, Bacitracin/Polymyxin B/Neomycin ointment (Yentuogin ointment) - Acne, Atopic Dermatitis | Not applicable | Not yet recruiting | National Taiwan University Hospital | 200 | 2026-04-01 | 2026-04-24 |
| Static Stretching Reshapes Post-RT Recovery Resistance Training, Resistance training + Static Stretching - Healthy, Healthy Subjects (HS) | Not applicable | Completed | University of Palermo | 28 | 2026-01-12 | 2026-06-16 |
| Effect of Hydrogen Gas on Hyperbaric Oxygen Toxicity Inhaled Hydrogen-Enriched Oxygen Gas, Inhaled Nitrogen-Enriched Oxygen Gas - Oxygen Toxicity, Oxidative Stress | Not applicable | Not yet recruiting | Blekinge Institute of Technology | 32 | 2026-01-01 | 2025-12-04 |
| Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metabolic Regulation in Adults Resistance Training, Resistance training + Static Stretching - Healthy, Healthy Participants | Not applicable | Completed | University of Palermo | 27 | 2025-12-15 | 2026-04-28 |
| A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2070 Injection SYH2070 injection, Placebo - Healthy Subjects (HS) | Phase 1 | Recruiting | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 48 | 2025-11-15 | 2025-12-01 |
| To Evaluate the Effect of Bacillus Coagulans Based Product in Gut Health and Immunomodulatory Effect in Healthy Adults Probiotic (Bacillus Coagulans), Placebo - Healthy Subjects (HS) | Not applicable | Enrolling by invitation | Bioagile Therapeutics Pvt. Ltd. | 46 | 2025-09-10 | 2026-01-30 |
| Evaluation of the Effectiveness of Teen Mental Health First Aid in Secondary School Students in Hong Kong A course of teen Mental Health First Aid to be provided to participants - Healthy Subjects (HS) | Not applicable | Enrolling by invitation | TN Foo Centre for Positive Mental Health | 250 | 2025-09-01 | 2025-09-29 |
| Physiological and Mood Changes After Walking in Green Spaces. A Comparison of Environments. WALK THROUGH ENVIRONMENT A, WALK THROUGH ENVIRONMENT B, WALK THROUGH ENVIRONMENT C - Healthy Subjects (HS), Forest Therapy | Not applicable | Completed | University of Vigo | 16 | 2025-07-27 | 2026-04-23 |
| Evaluation of 627 in Healthy Adult Subjects 627, Placebo - Healthy Subjects (HS) | Phase 1 | Not yet recruiting | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 108 | 2025-07-20 | 2025-07-15 |
| A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males [14C]SSS17 - Healthy Subjects (HS) | Phase 1 | Not yet recruiting | Shenyang Sunshine Pharmaceutical Co., LTD. | 6 | 2025-06-01 | 2025-06-25 |
Showing 20 of 36. Sign in to see all of them.
Acne Vulgaris (1) · Cardiovascular Diseases (1) · Dermatitis, Atopic (1) · Dermatitis, Seborrheic (1) · Disease (1) · Familial cylindromatosis (1) · Help-Seeking Behavior (1) · Hyperoxia (1) · Hypoxia (1) · Lewy Body Disease (1) · Lupus Erythematosus, Systemic (1) · Motor Activity (1) · Multiple System Atrophy (1) · Neurodegenerative Diseases (1) · Parkinson Disease (1)
Pathological Conditions, Signs and Symptoms (3) · Behavior (2) · Immune System Diseases (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2) · Skin and Connective Tissue Diseases (2) · Acneiform Eruptions (1) · Autoimmune Diseases (1) · Autonomic Nervous System Diseases (1) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1)
Muscle Stretching Exercises (3) · Injections (2) · Resistance Training (2) · Bacitracin (1) · Exercise (1) · Fluorodeoxyglucose F18 (1) · Iodine-123 (1) · Positron-Emission Tomography (1) · Probiotics (1) · Sodium Chloride (1) · Transcranial Magnetic Stimulation (1) · Vagus Nerve Stimulation (1) · ioflupane (1)
InSilico Medicine Hong Kong Limited (2) · Shenyang Sunshine Pharmaceutical Co., LTD. (2) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (2) · The Hong Kong Polytechnic University (2) · University of Palermo (2) · University of Vigo (2) · Yuhan Corporation (2) · Akeso (1) · American University of Beirut Medical Center (1) · Bioagile Therapeutics Pvt. Ltd. (1) · Biotech Pharmaceutical Co., Ltd. (1) · Blekinge Institute of Technology (1) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Ewan Thomas (1)
China (8) · Italy (4) · Hong Kong (3) · United States (3) · South Korea (2) · Australia (1) · Belgium (1) · Bulgaria (1) · France (1) · India (1) · Lebanon (1) · Spain (1) · Sweden (1) · United Arab Emirates (1) · United Kingdom (1)
Biao LI (1) · Fabio Moda, PHD (1) · Hyeonsoo Park, MD (1) · Parag Saudagar (1) · Shaheen Hamdy, PhD (1)
PMID 17486089, PMID 18081363, PMID 23475767, PMID 35168956, PMID 37029298, PMID 37364027, PMID 39911528, PMID 40483113, PMID 41044114